- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Companies
Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
100
Companies with a Value score of at least 3, ordered by Value score
100 companies
CanSino Biologics
Market Cap: HK$16.4b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$49.00
7D
-7.9%
1Y
133.3%
WuXi Biologics (Cayman)
Market Cap: HK$162.4b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269
HK$39.96
7D
1.9%
1Y
198.2%
Genscript Biotech
Market Cap: HK$35.1b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$16.06
7D
-5.5%
1Y
48.7%
SSY Group
Market Cap: HK$8.8b
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$2.99
7D
-2.6%
1Y
-20.9%
CSPC Pharmaceutical Group
Market Cap: HK$108.0b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$9.45
7D
-5.6%
1Y
80.3%
Zai Lab
Market Cap: HK$3.6b
A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.
9688
HK$25.26
7D
-0.2%
1Y
61.1%
Tong Ren Tang Technologies
Market Cap: HK$6.2b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$4.85
7D
-2.4%
1Y
-3.0%
WuXi Biologics (Cayman)
Market Cap: HK$162.4b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269
HK$39.96
7D
1.9%
1Y
198.2%
Kontafarma China Holdings
Market Cap: HK$167.7m
An investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediate in Mainland China, Singapore, Taiwan, and internationally.
1312
HK$0.03
7D
-25.0%
1Y
-11.8%
Austar Lifesciences
Market Cap: HK$553.6m
An investment holding company, engages in the provision of integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally.
6118
HK$1.08
7D
-5.3%
1Y
96.4%
Shanghai Haohai Biological Technology
Market Cap: HK$11.9b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$27.30
7D
-2.9%
1Y
-12.6%
SSY Group
Market Cap: HK$8.8b
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$2.99
7D
-2.6%
1Y
-20.9%
CSPC Pharmaceutical Group
Market Cap: HK$108.0b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$9.45
7D
-5.6%
1Y
80.3%
Genscript Biotech
Market Cap: HK$35.1b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$16.06
7D
-5.5%
1Y
48.7%
CSPC Pharmaceutical Group
Market Cap: HK$108.0b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$9.45
7D
-5.6%
1Y
80.3%
CanSino Biologics
Market Cap: HK$16.4b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$49.00
7D
-7.9%
1Y
133.3%
Biosino Bio-Technology and Science Incorporation
Market Cap: HK$125.9m
Manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China.
8247
HK$0.87
7D
-11.2%
1Y
27.9%
3SBio
Market Cap: HK$72.0b
An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.
1530
HK$30.10
7D
-3.5%
1Y
416.3%
Zai Lab
Market Cap: HK$3.6b
A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.
9688
HK$25.26
7D
-0.2%
1Y
61.1%
China Resources Pharmaceutical Group
Market Cap: HK$30.3b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.82
7D
-3.0%
1Y
-6.4%
SSY Group
Market Cap: HK$8.8b
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$2.99
7D
-2.6%
1Y
-20.9%
WuXi Biologics (Cayman)
Market Cap: HK$162.4b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269
HK$39.96
7D
1.9%
1Y
198.2%
China Resources Pharmaceutical Group
Market Cap: HK$30.3b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.82
7D
-3.0%
1Y
-6.4%
China Resources Pharmaceutical Group
Market Cap: HK$30.3b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.82
7D
-3.0%
1Y
-6.4%
Cutia Therapeutics
Market Cap: HK$3.1b
An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.
2487
HK$9.00
7D
-7.1%
1Y
-39.9%
3SBio
Market Cap: HK$72.0b
An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.
1530
HK$30.10
7D
-3.5%
1Y
416.3%
Jacobson Pharma
Market Cap: HK$2.9b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.45
7D
-1.4%
1Y
141.7%
Pak Fah Yeow International
Market Cap: HK$763.5m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.45
7D
-1.2%
1Y
-5.0%
Hua Medicine (Shanghai)
Market Cap: HK$4.1b
Engages in the development and commercialization of drugs for the treatment of diabetes in China.
2552
HK$4.20
7D
0.5%
1Y
255.9%
Livzon Pharmaceutical Group
Market Cap: HK$32.5b
Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People’s Republic of China.
1513
HK$34.50
7D
-5.3%
1Y
32.2%
Hansoh Pharmaceutical Group
Market Cap: HK$211.5b
An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.
3692
HK$34.94
7D
-3.5%
1Y
81.0%
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$7.5b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$8.93
7D
-2.8%
1Y
14.9%
Shandong Boan Biotechnology
Market Cap: HK$8.4b
A biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China.
6955
HK$13.45
7D
-5.9%
1Y
46.4%
Shanghai Henlius Biotech
Market Cap: HK$39.9b
Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.
2696
HK$73.45
7D
-11.8%
1Y
219.3%
Keymed Biosciences
Market Cap: HK$20.9b
A biotechnology company, engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas in Mainland China and internationally.
2162
HK$70.80
7D
-4.0%
1Y
96.9%
Duality Biotherapeutics
Market Cap: HK$29.5b
A clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.
9606
HK$335.00
7D
-26.0%
1Y
n/a